CN106511408A - Application of erythropalum scandens as medicine for treating prostatic disorders - Google Patents
Application of erythropalum scandens as medicine for treating prostatic disorders Download PDFInfo
- Publication number
- CN106511408A CN106511408A CN201611049276.4A CN201611049276A CN106511408A CN 106511408 A CN106511408 A CN 106511408A CN 201611049276 A CN201611049276 A CN 201611049276A CN 106511408 A CN106511408 A CN 106511408A
- Authority
- CN
- China
- Prior art keywords
- erythropalum scandens
- erythropalum
- scandens blume
- medicine
- blume
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000061498 Erythropalum scandens Species 0.000 title claims abstract description 74
- 239000003814 drug Substances 0.000 title claims abstract description 24
- 208000025844 Prostatic disease Diseases 0.000 title abstract description 5
- 201000007094 prostatitis Diseases 0.000 claims abstract description 30
- 230000027939 micturition Effects 0.000 claims abstract description 26
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims abstract description 18
- 208000004403 Prostatic Hyperplasia Diseases 0.000 claims abstract description 18
- 239000000284 extract Substances 0.000 claims abstract description 16
- 208000024891 symptom Diseases 0.000 claims abstract description 10
- 241000221014 Olacaceae Species 0.000 claims abstract description 7
- 241001031073 Erythropalum Species 0.000 claims abstract description 4
- 210000002700 urine Anatomy 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 206010013990 dysuria Diseases 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 13
- 239000003960 organic solvent Substances 0.000 claims description 6
- 230000001154 acute effect Effects 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 206010046543 Urinary incontinence Diseases 0.000 claims description 4
- 208000013507 chronic prostatitis Diseases 0.000 claims description 4
- 208000006750 hematuria Diseases 0.000 claims description 4
- 206010029446 nocturia Diseases 0.000 claims description 4
- 208000023121 splitting of urinary stream Diseases 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- 229940126701 oral medication Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 14
- 208000008967 Enuresis Diseases 0.000 abstract 1
- 210000002307 prostate Anatomy 0.000 description 22
- 208000015181 infectious disease Diseases 0.000 description 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 18
- 206010020880 Hypertrophy Diseases 0.000 description 16
- 201000010099 disease Diseases 0.000 description 16
- 230000001717 pathogenic effect Effects 0.000 description 12
- 201000001514 prostate carcinoma Diseases 0.000 description 9
- 201000005569 Gout Diseases 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 7
- 210000001015 abdomen Anatomy 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 241000345998 Calamus manan Species 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 235000012950 rattan cane Nutrition 0.000 description 6
- 230000001568 sexual effect Effects 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000003708 urethra Anatomy 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 210000004907 gland Anatomy 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 206010020718 hyperplasia Diseases 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 230000008506 pathogenesis Effects 0.000 description 4
- 208000035143 Bacterial infection Diseases 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 208000003800 Urinary Bladder Neck Obstruction Diseases 0.000 description 3
- 235000009392 Vitis Nutrition 0.000 description 3
- 241000219095 Vitis Species 0.000 description 3
- 208000022362 bacterial infectious disease Diseases 0.000 description 3
- 210000000981 epithelium Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000001018 virulence Effects 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 206010071445 Bladder outlet obstruction Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000000913 Kidney Calculi Diseases 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 241000588653 Neisseria Species 0.000 description 2
- 206010029148 Nephrolithiasis Diseases 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 102000013275 Somatomedins Human genes 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 239000003098 androgen Substances 0.000 description 2
- 230000001640 apoptogenic effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 208000013210 hematogenous Diseases 0.000 description 2
- 210000004969 inflammatory cell Anatomy 0.000 description 2
- 210000002570 interstitial cell Anatomy 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 201000003265 lymphadenitis Diseases 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000019419 proteases Nutrition 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- UUTKICFRNVKFRG-WDSKDSINSA-N (4R)-3-[oxo-[(2S)-5-oxo-2-pyrrolidinyl]methyl]-4-thiazolidinecarboxylic acid Chemical compound OC(=O)[C@@H]1CSCN1C(=O)[C@H]1NC(=O)CC1 UUTKICFRNVKFRG-WDSKDSINSA-N 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 206010005053 Bladder neck obstruction Diseases 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 235000018893 Cercis canadensis var canadensis Nutrition 0.000 description 1
- 240000000024 Cercis siliquastrum Species 0.000 description 1
- 241001503987 Clematis vitalba Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 241001573881 Corolla Species 0.000 description 1
- 241000006479 Cyme Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 206010071289 Lower urinary tract symptoms Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- 206010072353 Painful ejaculation Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- KLHSKTMVSOWVLD-WPDRYGPBSA-N Sumaresinol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2[C@H](O)C[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C KLHSKTMVSOWVLD-WPDRYGPBSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- SQEKGAVAEOAXJU-UHFFFAOYSA-N coniferyl cinnamate Natural products C1=C(O)C(OC)=CC(C=CCOC(=O)C=CC=2C=CC=CC=2)=C1 SQEKGAVAEOAXJU-UHFFFAOYSA-N 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000001461 cytolytic effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- QDOXWKRWXJOMAK-UHFFFAOYSA-N dichromium trioxide Chemical compound O=[Cr]O[Cr]=O QDOXWKRWXJOMAK-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000008508 epithelial proliferation Effects 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000009681 mesenchymal cell proliferation Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 244000039328 opportunistic pathogen Species 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- KLHSKTMVSOWVLD-UHFFFAOYSA-N sumaresinolic acid Natural products C1CC(O)C(C)(C)C2C(O)CC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C KLHSKTMVSOWVLD-UHFFFAOYSA-N 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- BPJYAXCTOHRFDQ-UHFFFAOYSA-L tetracopper;2,4,6-trioxido-1,3,5,2,4,6-trioxatriarsinane;diacetate Chemical compound [Cu+2].[Cu+2].[Cu+2].[Cu+2].CC([O-])=O.CC([O-])=O.[O-][As]1O[As]([O-])O[As]([O-])O1.[O-][As]1O[As]([O-])O[As]([O-])O1 BPJYAXCTOHRFDQ-UHFFFAOYSA-L 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses application of erythropalum scandens (scientific name: Erythropalum scandens B1.) as a medicine for treating prostatic disorders. Olacaceae Erythropalum perennial evergreen large woodiness lianas are dried in the sun and powdered or an extract is used for treating the male prostatic disorders including prostatitis, prostatic hyperplasia, and the erythropalum scandens has remarkable effects on symptoms such as frequent micturition, urgent urination, odynuria, hematuresis, dysuresia, uroclepsia, bifurcation of urination, post-urine drops and frequent enuresis nocturna occurred in the prostatic disorders.
Description
Technical field
The present invention relates to the medical field for the treatment of by Chinese herbs difficult miscellaneous diseases, specifically a kind of Erythropalum Scandens Blume or extract are used for controlling
Treat the purposes of prostatosis.
Background technology
Prostatosis are the common diseases of adult male, are often referred to prostatitis, prostatic hyperplasia and carcinoma of prostate etc.,
Wherein：
The inflammation of the 1st, prostatitis, i.e. prostate.It is broadly divided into acute and chronic, but pathogenesiss are by antibacterial and non-bacterial sense
Dye causes.Cardinal symptom dysurea, greasy urine, urine burn, frequent micturition, and lower abdomen perineal position distending pain is uncomfortable；When more serious, may result in and send out
Heat.I type prostatitis pathogenic infection is main pathogenic.Due to Abwehrkraft des Koepers it is low, the stronger antibacterial of virulence or its
His pathogenic infection prostate simultaneously breed and cause by rapid raised growth, mostly hematogenous infection and per urethra retrograde infection.Cause of disease
Body is mainly escherichia coli, and most is single pathogenic bacterial infection.II type prostatitis paathogenic factor is also mainly cause of disease
Body-sensing contaminates, but Abwehrkraft des Koepers relatively strong or/and pathogen virulence is weaker, and based on retrograde infection, pathogen is mainly Fructus Vitis viniferae ball
Pseudomonas.III type prostatitis pathogenesis are unknown, and etiology is sufficiently complex, and most scholars think that its Etiological is probably cause of disease
The collective effect of the basin bottom neuron-muscular activity of body-sensing dye, inflammation and exception etc..
2nd, the generation of prostatic hyperplasia must possess two essential conditions of growth and functional testis at age.But prostatitis
The concrete mechanism that gland hypertrophy occurs is still not clear, it may be possible to due to epithelium and the propagation and apoptotic balance of Interstitial cell
Destruction causes.Correlative factor has：Androgen and its epithelioglandular mutually with the interaction of estrogen, prostate interstitial one
Effect, somatomedin, inflammatory cell, neurotransmitter and inherited genetic factorss etc..Prostatic hyperplasia has benign and malignant prostatic hyperplasia
（Carcinoma of prostate）；
Benign prostatic hyperplasia, benign prostatic hyperplasia are to cause most commonly seen one kind in middle-aging male dysuria reason
Benign disease.The prostate interstitial being mainly shown as on histology and the hypertrophy of body of gland composition, prostatitis hylperadenosis anatomically,
The bladder outlet obstruction (BOO) in clinical symptoms and urodynamicss based on lower urinary tract symptom.Carcinoma of prostate early stage is more without special disease
Shape, when growth of cancer cells, body of prostate is loose, extrudes urethra and causes dysuria.These cancerous cell can expand with blood
It is scattered to body other parts.Exhibition when the general course of disease is in slow, late period can cause the symptoms such as bladder neck obstruction and metastasis.Draw
The risk factor for playing carcinoma of prostate is not yet clear and definite, but some of them have been identified.One of most important factor is heredity.Such as
A really lineal relative（Brother or father）With carcinoma of prostate, the danger that he or she suffers from carcinoma of prostate can double.Outward
Source sexual factor can affect the process from so-called resting form carcinoma of prostate to clinical type carcinoma of prostate.The confirmation of these factors is still
Under discussion, but high Animal fat diet is an important risk factor.
3rd, prostatosis clinical manifestation, prostatosis can behave as frequent micturition, urgent micturition, dysurea, hematuria, dysuria,
Drip drop, nocturia increased frequency after urinary incontinence, splitting of urinary stream, urine, after urine or it is big drip after an action of the bowels it is white.And can concurrent sexual dysfunction, bag
Hyposexuality, premature ejaculation is included, painful ejaculation, is erected and is weakened and sexual impotence, or even the infringement of secondary upper urinary tract, and General Symptomies etc..
4th, prostatosis prevention
（1）Prostatitis；Avoid congestion of prostate, should note avoiding pungent food in life, discontinue the habit of smoking and drinking, guard against catch a cold, guard against sitting,
Guard against sexual life frequently immoderate etc..The custom formed, that Jing is normal to drink water, and should not suppress urine.Note striking a proper balance between work and rest, can so change
Kind prostatic blood circulation, improves the equilibrium between yin and yang of itself, the prostatitic generation of prevention aseptic.
（2）Prostatic hyperplasia；Pungent excitant food is eaten less；Urine is not excessively suppressed, otherwise bladder excessive is filled, and can make bladder
Detrusor muscle tension weakens, and urination occurs difficult.Can not overwork, it is overworked can consume damaging the spleen and stomach gas, deficiency of QI in middle-JIAO can cause nothing of urinating
Power, easily causes urine retention.Sitting, sitting is avoided easily to make perineal position congested, cause dysuria.Appropriate to drink water, night is appropriate
Drinking-water is reduced, in order to avoid sleep rear bladder excessive filling, daytime should drink more water.Careful clothes can cause the medicine of urine retention, such as atropine, top
Eggplant piece etc..
（3）Carcinoma of prostate；Heredity is important risk factor of the prostate cancer development into clinical type, and extrinsic factor is to this
Planting danger may have important impact.Key issue is to there is no enough evidences to advise living-pattern preservation now（Reduce dynamic
The intake of thing fat intake and increase fruit, frumentum, vegetable, red wine etc.）Onset risk can be reduced.
The content of the invention
It is an object of the invention to provide it is a kind of for treating prostatic diseases, including prostatitis, prostatic hyperplasia,
Drip drop and nocturia after frequent micturition, urgent micturition, dysurea, hematuria, dysuria, urinary incontinence, splitting of urinary stream, urine to prostatosis appearance
Increased frequency has the medicine of the effect of notable treatment.It is particularly well-suited to the middle-aging male crowd for suffering from prostatosis.
Medicine of the present invention is Erythropalum Scandens Blume（Erythropalum scandens Bl.）.
Described Erythropalum Scandens Blume（Erythropalum scandens Bl.）It is Olacaceae（Olacaceae）Erythropalum Scandens Blume belongs to
（Erythropalum）The large-scale bejuco of perennial evergreen.
Described Erythropalum Scandens Blume is dried for Herb and beats powder product or extract product.
Described extract product adds organic solvent extraction for water extract or extractive with organic solvent, or water extract
The mixture of thing.Such as ethanol extraction, ether extract, ethyl acetate extract.
Described Erythropalum Scandens Blume Herb dries the product for beating that powder product also decomposes ferment treatment including powdery Erythropalum Scandens Blume through Chinese medicine,
For example Erythropalum Scandens Blume powder adds protease, lipase, amylase, one or more enzyme of cellulolytic enzyme.Enzymolysis processing
Process is enzyme or mixed enzyme are added to Erythropalum Scandens Blume to carry out enzymolysis under certain condition to obtain.
Described extract product can make oral drug preparation, such as oral liquid, granule, tablet, capsule, pill
Deng.
Described prostatosis include acute and chronic prostatitis, prostatic hyperplasia；
Purposes of the Erythropalum Scandens Blume of the present invention as treatment prostatosis medicine, acute and chronic prostatitis in described prostatosis
Adenitises, the clinical symptoms of prostatic hyperplasia include frequent micturition, urgent micturition, dysurea, hematuria, dysuria, urinary incontinence, splitting of urinary stream, urine
Drip is dripped or nocturia increased frequency afterwards.
Erythropalum Scandens Blume（Classification system：Erythropalum scandens Bl.）Another name, the ears of an ox or cow rattan, the rattan that withers (Hainan Island) hook
China, side Herba Amaranthi tricoloriss (Guangxi), thin green rattan (Yunnan), are Olacaceae（Olacaceae）Erythropalum Scandens Blume belongs to（Erythropalum）It is perennial
Evergreen large-scale bejuco.Erythropalum Scandens Blume have higher edible, medicinal and afforestation ornamental value, main product in Guangxi,
The ground such as Yunnan, Guizhou, Guangdong；China Guangxi, Guangdong are grown in that height above sea level 280-550m is regional, and Yunnan, Guizhou are grown in height above sea level
1000 ~ 1500m is regional, is more common in border or the shrubbery of low mountain and knob or mountain area small stream side, mountain valley, thick forest or sparse woods.
External distribution：India, Nepal, Burma, Vietnam, Laos, Malaysia, Indonesia, Philippine.
Erythropalum Scandens Blume is the precious medicinal plants grown in overhanging cliff crack of stone.Erythropalum Scandens Blume is evergreen large-scale woody climber, grows 5
~ 15m, branch is dense and extends to the periphery, its well developed root system, strong adaptability, easily breeds.Flower lines up the forked cyme of axil life
Sequence, corolla white, calyx cylinder top have the wavy carnassial tooth for harboring, and reddish tan when ripe is yellowish-brown after doing.Leaf papery is to thickness
Papery, it is avette, above leaf green, the back side powder green, form sagging fruit, bluish violet when ripe, be very excellent sight leaf,
See fruit landscape seeds, great ornamental value.Erythropalum Scandens Blume can also be made garden ornamental tree species, hedgerow and make domatic vertical greening tree
Kind, it is also possible to plant by courtyard, flower stand, allow which to climb nature Cheng Jing.
Document report, treatment of the Erythropalum Scandens Blume to diseases such as metabolic arthritis, gout, renal calculuss, frequent micturition, urgent micturition, dysureas extremely have
Effect.Erythropalum Scandens Blume tea washes kidney toxin expelling, and deacidification controls gout, Erythropalum Scandens Blume【Cure mainly】：For dampness-heat in the liver and gallbladder, stomachache, diarrhoea,【Work(
Effect】To rheumatoid arthritiss, gout, jaundice, dampness-heat in the liver and gallbladder, calculus diuresis, lithangiuria, expelling wind and activating blood circulation, chronic nephritiss,
The diseases such as cystitis, renal calculuss are effective in cure.【Effective ingredient】Sexual element containing phenol in Erythropalum Scandens Blume, resin and triterpene, resin it is main
Composition is sumaresinolic acid, coniferyl cinnamate.【Meridian distribution of property and flavor】：Hardship, puts down.Enter liver, kidney two warp.But have no Erythropalum Scandens Blume
For the report as treatment prostatosis medicine.
Erythropalum Scandens Blume is numerous in variety, can grow several Erythropalum Scandens Blume simultaneously, be divided into green bud and red bud in same ecological environment
Erythropalum Scandens Blume, effect are identical.Erythropalum Scandens Blume is the edible wild herbs of the torrid zone and subtropical zone distribution, is also a kind of natural nuisance-free
Untapped wild plant resource.The tender sharp leaf edible of Erythropalum Scandens Blume, can be used to eat raw, stir-fries and eats, cooks filling, cook soup, cook medicated porridge, pickle
Deng, delicious flavour, delicate fragrance Yi Kou, and unique flavor, it is among the people with collection tender shoots in south of Yunnan and Guangxi, Guangdong, Hainan etc.
Edible custom.
Inventors believe that Erythropalum Scandens Blume as the mechanism for the treatment of prostatosis medicine is：
Document is introduced, Erythropalum Scandens Blume【Effect】：Clearing away heat and promoting diuresis.【Cure mainly】：For diseases such as dampness-heat in the liver and gallbladder, stomachache, diarrhoea.【Nature and flavor
Return through】：Hardship, flat, enter liver, kidney two warp.【Effect】Rheumatoid arthritiss, gout, jaundice, dampness-heat in the liver and gallbladder, calculus diuresis are had
Therapeutical effect.
And prostatitis, pathogenesiss cause by antibacterial and non-bacterial infection.Cardinal symptom dysurea, greasy urine, urine burn, urine
Frequently, lower abdomen perineal position distending pain is uncomfortable；When more serious, heating is may result in.I type prostatitis pathogenic infection is principal causative
Factor.Due to Abwehrkraft des Koepers lowly, simultaneously rapid raised growth is numerous for the stronger antibacterial of virulence or other pathogens infection prostate
Grow and cause, mostly hematogenous infection and per urethra retrograde infection.Pathogen is mainly escherichia coli, and most is single disease
Opportunistic pathogen infects.II type prostatitis paathogenic factor is also mainly pathogenic infection, but Abwehrkraft des Koepers relatively strong or/and pathogen poison
Power is weaker, and based on retrograde infection, pathogen is mainly staphylococcus.III type prostatitis pathogenesis are unknown, etiology
Sufficiently complex, most scholars think that its Etiological is probably the basin bottom neuron-muscular activity of pathogenic infection, inflammation and exception
Deng collective effect；The generation of prostatic hyperplasia must possess two essential conditions of growth and functional testis at age.But
The concrete mechanism that prostatic hyperplasia occurs is still not clear, it may be possible to due to the propagation of epithelium and Interstitial cell and apoptotic flat
The destruction of weighing apparatus property causes.Correlative factor has：Androgen and its epithelioglandular with the interaction of estrogen, prostate interstitial one
Interaction, somatomedin, inflammatory cell, neurotransmitter and inherited genetic factorss etc..
When male reaches the middle age, what is had does not note maintenance, and sexual life is uncontrolled, and Abwehrkraft des Koepers die down, or
Long-time is sat and works motionless at a desk, and prostate is oppressed, and will cause dysurea, greasy urine, urinate bright, frequent micturition, lower abdomen meeting
Pudendum distending pain is uncomfortable, prostate may epithelium and mesenchymal cell proliferation, if unclean sexual life, be also easy to catch antibacterial
Infection, accelerates the development of prostatitis.
Due to Erythropalum Scandens Blume【Effect】：Clearing away heat and promoting diuresis.【Meridian distribution of property and flavor】：Hardship, flat, enter liver, kidney two warp, can be to non-infection
The bacterial prostate hyperplasia of property or hypertrophy play inhibitory action；There are prostatitis when bacterium infection is caught, before causing
Row gland hypertrophy or hypertrophy, and after bacterium infection is cured, after Erythropalum Scandens Blume is for oral administration, kidney toxin expelling can be washed, removing the necrotic tissue and promoting granulation, before reparation
Row gland hypertrophy or hypertrophy or inflammation.Here it is the result that the present inventor is drawn after testing several years.
Utstanding substantial characteristics and significant improvement of the present invention：
1st, propose Erythropalum Scandens Blume first as treatment prostatosis medicine, open the new neck for the treatment of by Chinese herbs prostatosis
Domain.
2nd, propose to dry using Erythropalum Scandens Blume Herb and beat powder product or extract product.Described extract product is water extraction
Thing or extractive with organic solvent, or water extract adds the mixture of extractive with organic solvent.Or powdery Erythropalum Scandens Blume Jing
The product that Chinese medicine decomposes ferment treatment is crossed, past Erythropalum Scandens Blume be can be used in into treatment gout medicine and further extended its purposes.
3rd, non-infectious bacterial prostate hyperplasia or hypertrophy are the diseases of many middle-aged males, are sitting in for a long time and do
Work motionless before public table, prostate is oppressed, prostate hyperplasia or hypertrophy just occurs, antibacterial also easily invades, and causes inflammation
, there is dysurea, greasy urine, urinates bright, frequent micturition in disease, and lower abdomen perineal position distending pain is uncomfortable.After taking Erythropalum Scandens Blume, general 3-5 days, perineal position
Distending pain is uncomfortable, dysuria can be retarded, 5-10 days or so, and dysurea, greasy urine, urine burns, frequent micturition also can be with disappearance.
If the 4, belonging to alien bacteria infection urethra, such as Fructus Vitis viniferae bacillus, gonococcuss etc. invade prostate, cause prostatitis
Disease, hypertrophy or hypertrophy, then after needing to cure bacterium infection, then treated with Erythropalum Scandens Blume, effect will be very good, no
Easily stay and leave disease.
Description of the drawings
Fig. 1 is the picture of Erythropalum Scandens Blume shoot.
Fig. 2 is the picture that Erythropalum Scandens Blume grows fruit.
Specific embodiment
Erythropalum Scandens Blume medicine preparation embodiment：
Embodiment 1
The wild Erythropalum Scandens Blume of collection, removes yellow leaf and impurity, cleans, and Herb is dried, then with microwave drying to water content 10%
Within, beat powder and cross 200 mesh, be vacuum-packed or place coloured sealed glass jars standby.
Embodiment 2
The wild Erythropalum Scandens Blume of collection, removes yellow leaf and impurity, cleans, leaf is individually peeled, is dried and is cut into pieces, and steeps as bag
Tea；Rhizome dry after with microwave drying to water content within 10%, beat powder and cross 200 mesh, be vacuum-packed or place coloured close
Envelope vial is standby.
Embodiment 3
The wild Erythropalum Scandens Blume of collection, removes yellow leaf and impurity, cleans, and Herb is dried, then with microwave drying to water content 10%
Within, to beat powder and cross 100 mesh, be initially charged the alcohol reflux of 70%-90% 2 hours, reclaim ethanol and obtain thick paste, medicinal residues add 5 times
Clear water is boiled 2 hours, concentration, is merged with thick paste, is made granule or tablet.
Embodiment 4
The wild Erythropalum Scandens Blume of collection, removes yellow leaf and impurity, cleans, and Herb is dried, then with microwave drying to water content 10%
Within, to beat powder and cross 100 mesh, add aether backflow to extract 2 hours, reclaim ether and obtain thick paste, medicinal residues add 5 times of clear water to boil 2 hours,
Concentration, is merged with thick paste, makes granule or tablet.
Embodiment 5
2-3 times of water is added by Erythropalum Scandens Blume grain weight amount, is added according to protease, lipase, amylase weight 1:1:1 mixing
Enzyme, mixed enzyme weight are the 1% of grey rattan grain weight amount；Digested, the time is 5-10 hours, and temperature is 25-40 DEG C；Then it is dried,
Obtain grey rattan powder enzymolysis product.
Situation of the Erythropalum Scandens Blume of the present invention as treatment prostatosis medicine：
Started from 2014, Erythropalum Scandens Blume is being suffered from as during treatment gout, finding to have simultaneously by the present inventor
Gout and prostatitis or hypertrophy, there is dysuric patient effective in cure, so, introduced by hospital or friend, had more than 30
Position causes prostatitic patient by bacterium infection and non-bacterial（Volunteer）Treatment test is carried out, the present inventor understands disease first
The medical history of people, when belonging to harmful bacteria（Fructus Vitis viniferae bacillus, streptococcus, gonococcuss etc.）Infection urethra, the patient of prostate inflammation, arrive first
Hospitalize, bacterial disease is cured, then to prostatitis or hypertrophy, have dysuric patient carry out Erythropalum Scandens Blume to
Medicine treat, 2014-2015, patient take the Herb of embodiment 1 and 2 dry beat powder product, daily 2 times, each 5-8 gram, 20
In people, there are 17 human prostate inflammation or hypertrophy, have dysuric patient 5 days i.e. effective；
In Jan-Sept, 2016, there are 15 prostatitis or hypertrophys, have dysuric patient（Exclude std patient）Have urine to burn,
Frequent micturition, lower abdomen perineal position distending pain situation, takes the Erythropalum Scandens Blume extract product of embodiment 3-5, in 15 people, daily 2 times, every time
0.5-1 gram, there can be symptom to improve within 3-5 days, there are 3 Genus Homos in row adenitises disease for many years and hypertrophy patient, feel dysuria 10 days
Having later improves symptom.
Case 1：
Wu, man, 42 years old, certain unit secretary write material due to being sitting in hardboard stool daily, and there are prostatitis adenoncus in March, 2015, discovery
Swollen situation, uriesthesia pain, frequent micturition, hospital diagnosis are prostatic hyperplasia, later using the powder of the Erythropalum Scandens Blume of the embodiment of the present invention 1
Last product, daily 2 times, 6 grams every time, and hardboard stool is replaced by into rattan chair, using 5 days, dysuria symptom had improvement, takes 10
Disappear after it.
Case 2：
Zhang, 56 years old, certain university research institute researcher, daily more than 12 hours before computer a little materials, add and be not careful in one's diet,
Jing often eats fried food and Fructus Capsici, in June, 2015, and discovery has uriesthesia pain, frequent micturition, and hospital diagnosis are prostatitis, are passed through
With the Erythropalum Scandens Blume granule of the embodiment of the present invention 3, once a day, 1 gram every time, using the situation of uriesthesia pain, frequent micturition after 5 days
Start to reduce, slowly fully recover later within 30 days, illustrate that Erythropalum Scandens Blume of the present invention can repair prostate.
Case 3：
It is deep so-and-so, man, 45 years old, certain business event person, Jing often drink by dinner party, and there are pouring in April, 2015, excessively unclean sexual life, discovery
Coccus infects, urodynia, frequent micturition, and after hospital treatment, gonorrhea is cured, but does not note, is also on the drink, causes prostate to increase
Raw, prostate tumorous situation, later using the tablet of the Erythropalum Scandens Blume of the embodiment of the present invention 3, daily 2 times, 1 gram every time, makes
With 15 days, prostatic hyperplasia, prostate tumorous situation had improvement.
Case 4：
Lu, man, 51 years old, peasant, daily breakfast, lunch and dinner drank, not liquor-saturated not give up；In January, 2016, find to urinate bright, frequent micturition, lower abdomen
Perineal position distending pain is uncomfortable, checks that for prostatic hyperplasia, prostate hyperplasia, later using the bag of the Erythropalum Scandens Blume of the embodiment of the present invention 2
Make tea product, sooner or later 1 time daily, 5 grams every time, using 15 days, urine burnt, frequent micturition, and lower abdomen perineal position distending pain discomfort situation has improvement.
Claims (7)
1. Erythropalum Scandens Blume is used as the purposes for treating prostatosis medicine；Described Erythropalum Scandens Blume（Erythropalum scandens
Bl.）It is Olacaceae（Olacaceae）Erythropalum Scandens Blume belongs to（Erythropalum）The large-scale bejuco of perennial evergreen.
2. Erythropalum Scandens Blume according to claim 1 is used as the purposes for treating prostatosis medicine, it is characterised in that：Described
Erythropalum Scandens Blume is dried for Herb and beats powder product or extract product.
3. Erythropalum Scandens Blume according to claim 2 is used as the purposes for treating prostatosis medicine, it is characterised in that extract
Product adds the mixture of extractive with organic solvent for water extract or extractive with organic solvent, or water extract.
4. Erythropalum Scandens Blume according to claim 2 is used as the purposes for treating prostatosis medicine, it is characterised in that：Described
Erythropalum Scandens Blume Herb dries dozen powder product includes product of the powdery Erythropalum Scandens Blume through Chinese medicine ferment treatment.
5. Erythropalum Scandens Blume according to claim 2 is used as the purposes for treating prostatosis medicine, it is characterised in that：Described
Extract product can make oral drug preparation.
6. Erythropalum Scandens Blume according to claim 1 is used as the purposes for treating prostatosis medicine, it is characterised in that：Described
Prostatosis include acute and chronic prostatitis and prostatic hyperplasia.
7. Erythropalum Scandens Blume according to claim 7 is used as the purposes for treating prostatosis medicine, it is characterised in that：Described
Acute and chronic prostatitis and prostatic hyperplasia in prostatosis；Clinical symptoms include that frequent micturition, urgent micturition, dysurea, hematuria, urination are tired
Drip drop or nocturia increased frequency after hardly possible, urinary incontinence, splitting of urinary stream, urine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611049276.4A CN106511408A (en) | 2016-11-25 | 2016-11-25 | Application of erythropalum scandens as medicine for treating prostatic disorders |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611049276.4A CN106511408A (en) | 2016-11-25 | 2016-11-25 | Application of erythropalum scandens as medicine for treating prostatic disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106511408A true CN106511408A (en) | 2017-03-22 |
Family
ID=58357119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611049276.4A Pending CN106511408A (en) | 2016-11-25 | 2016-11-25 | Application of erythropalum scandens as medicine for treating prostatic disorders |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106511408A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107951922A (en) * | 2017-12-08 | 2018-04-24 | 杨英珠 | Erythropalum Scandens Blume deacidification tea and preparation method thereof |
| CN108743634A (en) * | 2018-06-26 | 2018-11-06 | 广西医科大学 | A kind of preparation method of granules of civil medicine-food two-purpose Erythropalum Scandens Blume |
| CN109010390A (en) * | 2018-08-20 | 2018-12-18 | 林爵文 | A kind of health care product improving male's sexual and the treatment of sexual dysfunction |
-
2016
- 2016-11-25 CN CN201611049276.4A patent/CN106511408A/en active Pending
Non-Patent Citations (3)
| Title |
|---|
| 冯旭等: "赤苍藤叶挥发油化学成分分析", 《时珍国医国药》 * |
| 刘文峰等主编: "《刘文峰中医学术思想及临床经验集》", 31 January 2016, 中国中医药出版社 * |
| 蔡永敏主编: "《中药药名辞典》", 31 October 1996, 中国中医药出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107951922A (en) * | 2017-12-08 | 2018-04-24 | 杨英珠 | Erythropalum Scandens Blume deacidification tea and preparation method thereof |
| CN108743634A (en) * | 2018-06-26 | 2018-11-06 | 广西医科大学 | A kind of preparation method of granules of civil medicine-food two-purpose Erythropalum Scandens Blume |
| CN109010390A (en) * | 2018-08-20 | 2018-12-18 | 林爵文 | A kind of health care product improving male's sexual and the treatment of sexual dysfunction |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104758257B (en) | Fresh dendrobium candidum freeze-dried powder and preparation method | |
| CN104381713A (en) | Compound feeds for sheep and preparation method for compound feeds | |
| CN101554462B (en) | Medicament for curing cancer | |
| CN106581091A (en) | Extraction method of erythropalum scandens and application as medicine treating gout | |
| moghaddasi Mohammad | Study on Cammomile (Matricaria chamomilla L.) usage and Farming | |
| KR20160037510A (en) | Fermented foods improve bowel function and a method of manufactuing stercoral removal efficacy | |
| CN102370756A (en) | Chinese patent drug and Chinese medicine decoction capable of effectively curing intestinal cancer, liver cancer, uterine cancer and stomach cancer | |
| CN107156828A (en) | A kind of full nutrition formula food suitable for patients with inflammatory bowel | |
| CN106511408A (en) | Application of erythropalum scandens as medicine for treating prostatic disorders | |
| CN104256166A (en) | Functional feed for treating bovine bluetongue and preparation method thereof | |
| CN104288577A (en) | Traditional Chinese medicine preparation for preventing and curing hog flu and pneumonia, and preparation method thereof | |
| KR20130137066A (en) | Manufacturing process of makgeolli mixed with winter melon | |
| CN106701410A (en) | Healthcare wine capable of strengthening stomach and tonifying qi and production method thereof | |
| KR20110080817A (en) | The healthy beverage manufactacturing method | |
| CN106805235A (en) | A kind of full nutrition formula food suitable for respiratory disease patient | |
| CN107156829A (en) | A kind of full nutrition formula food suitable for hepatopath | |
| KR101479228B1 (en) | chicken soup | |
| CN104996649A (en) | Artemisia argyi corolla tea and processing method thereof | |
| CN107261009A (en) | Careless rice straw compatibility field thistle antigout tea of rice and preparation method thereof | |
| CN105597057A (en) | Method for preparing traditional Chinese medicine composition powder for treating acute nephritis | |
| CN107581153A (en) | A kind of method of black bottom soft-shelled turtle ecologic breeding | |
| CN103860948B (en) | Be used for the treatment of stagnation of the circulation of vital energy heat and stop up Chinese medicine of card acute mastitis and preparation method thereof | |
| CN104996659A (en) | Health-care herb tea contained in cups and production method of health-care herb tea | |
| KR102632013B1 (en) | A composition containing herbs extract, and manufacturing method of the same | |
| CN108893222A (en) | A kind of Zhuang rural area alcoholic drink mixed with fruit juice and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170322 |